Are you suffering from itch?
CLICK HERE FOR MORE INFORMATION:

The Study
- A Phase 3, 4-week study reviewing the safety of a topical cream given QD in mild atopic dermatitis subjects
Study Benefits*
- Study the safety and efficacy of an investigational topical cream for mild to moderate atopic dermatitis
- Being studied in both children and adults
- The study drug is a PD4-inhibitor
- PD4 has been associated with higher production of pro-inflammatory mediators and lower production of the anti-inflammatory mediator IL-10
- Therefore, the study drug works to directly block the PD4 and block inflammation of the skin
- Non-steroidal topical cream with once daily dosing
- All study related care and medication provided
- Open label extension study available
Study Volunteers Must Meet the Following Criteria
- 6 years and older with a diagnosis of mild to moderate atopic dermatitis
- Not pregnant or breastfeeding or planning to do so
Study Participant Expectations
- 2-month study duration with 5 study visits
- Blood samples collected 3 times during course of study
- Optional medical photography portion of the study available
- Optional open label study available that allows participants to continue to receive the study treatment
Cost
- There is no cost to participate
- Patients who qualify may be compensated for time and travel